Literature DB >> 25774440

Predictions instead of panics: the framework and utility of systematic forecasting of novel psychoactive drug trends.

John M Stogner1.   

Abstract

BACKGROUND: Countless novel psychoactive substances have been sensationally described in the last 15 years by the media and academia. Though some become significant issues, most fail to become a substantial threat. The diversity and breadth of these potential problem substances has led policymakers, law enforcement officers, and healthcare providers alike to feel overwhelmed and underprepared for dealing with novel drugs.
OBJECTIVE: Inadequacies in training and preparation may be remedied by a response that is more selective and more proactive. The current manuscript seeks to clarify how to most efficiently forecast the "success" of each newly introduced novel psychoactive substance in order to allow for more efficient decision making and proactive resource allocation.
METHODS: A review of literature, published case reports, and legal studies was used to determine which factors were most closely linked to use of a novel drug spreading. Following the development of a forecasting framework, examples of its use are provided.
RESULTS: The resulting five-step forecast method relies on assessments of the availability of a potential user base, the costs--legal and otherwise--of the drug relative to existent analogues, the subjective experience, the substance's dependence potential and that of any existent analogue, and ease of acquisition. These five factors should serve to forecast the prevalence of novel drug use, but reaction should be conditioned by the potential for harm.
CONCLUSIONS: The five-step forecast method predicts that use of acetyl fentanyl, kratom, Leonotis leonurus, and e-cigarettes will grow, but that use of dragonfly and similar substances will not. While this forecasting approach should not be used as a replacement for monitoring, the use of the five-step method will allow policymakers, law enforcement and practitioners to quickly begin targeted evaluative, intervention, and treatment initiatives only for those drugs with predicted harm.

Entities:  

Keywords:  Acetyl fentanyl; Bromo-Dragonfly; drug policy; forecasting; novel drugs; novel psychoactive substances

Mesh:

Substances:

Year:  2015        PMID: 25774440     DOI: 10.3109/00952990.2014.998367

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  5 in total

1.  Improving the analysis and modeling of substance use.

Authors:  David A Gorelick; Sterling McPherson
Journal:  Am J Drug Alcohol Abuse       Date:  2015-09-25       Impact factor: 3.829

2.  Two Fatal Intoxications Involving Butyryl Fentanyl.

Authors:  Justin Poklis; Alphonse Poklis; Carl Wolf; Cindie Hathaway; Elise Arbefeville; Leszek Chrostowski; Kelly Devers; Laura Hair; Mary Mainland; Michele Merves; Julia Pearson
Journal:  J Anal Toxicol       Date:  2016-06-23       Impact factor: 3.367

3.  The long tail of a demon drug: The 'bath salts' risk environment.

Authors:  Luther Elliott; Ellen Benoit; Stephanie Campos; Eloise Dunlap
Journal:  Int J Drug Policy       Date:  2017-12-15

4.  Postmortem tissue distribution of acetyl fentanyl, fentanyl and their respective nor-metabolites analyzed by ultrahigh performance liquid chromatography with tandem mass spectrometry.

Authors:  Justin Poklis; Alphonse Poklis; Carl Wolf; Mary Mainland; Laura Hair; Kelly Devers; Leszek Chrostowski; Elise Arbefeville; Michele Merves; Julia Pearson
Journal:  Forensic Sci Int       Date:  2015-10-26       Impact factor: 2.395

Review 5.  Following "the Roots" of Kratom (Mitragyna speciosa): The Evolution of an Enhancer from a Traditional Use to Increase Work and Productivity in Southeast Asia to a Recreational Psychoactive Drug in Western Countries.

Authors:  Eduardo Cinosi; Giovanni Martinotti; Pierluigi Simonato; Darshan Singh; Zsolt Demetrovics; Andres Roman-Urrestarazu; Francesco Saverio Bersani; Balasingam Vicknasingam; Giulia Piazzon; Jih-Heng Li; Wen-Jing Yu; Máté Kapitány-Fövény; Judit Farkas; Massimo Di Giannantonio; Ornella Corazza
Journal:  Biomed Res Int       Date:  2015-11-10       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.